Back to results
US 2023/0145481 A1Published application
Substituted benzenecarboxamides as il-17a modulators
AssigneeDice Alpha, Inc.
InventorsPaul R. FATHEREE, Martin S. LINSELL, John R. JACOBSEN, Wouter A. VAN DER LINDEN, Timothy J. CHURCH, Claudio AQUINO, Margot G. PAULICK
Life of this patent
Estimating the term…
Abstract
The disclosure herein provides compounds and pharmaceutical compositions of the structure of Formula I: for the modulation of IL-17A, useful for the treatment of inflammatory conditions, such as psoriasis.
Claims30
A compound represented by the structure of Formula ID:
- or a pharmaceutically acceptable salt thereof wherein:
- is selected from pyrazole, tetrazole, oxadiazole, isoxazole, pyrrole, and furan any one of which is optionally substituted with one or more substituents independently selected from halogen,
- —OR11, —N(R11)2, —N(R11)S(O)2R11, —NO2, —CN, C1-6 alkyl, —C1-6 alkyl-C3-5 carbocycle, C3-5 carbocycle, and 3- to 5-membered heterocycle;
- is selected from cyclopentyl, cyclohexyl, and cycloheptyl each of which is optionally substituted with one or more substituents independently selected from halogen, —OR12, and optionally substituted C1-3 alkyl;
- R4 is
- wherein
- is selected from azetidine, piperidine, piperazine, morpholine, thiomorpholine, thiomorpholine 1,1-dioxide, and azaspiro[3.3]heptane any of which is optionally substituted with one or more substituents independently selected from halogen,
- —OR13, and optionally substituted C1-3 alkyl;
- RB is selected from hydrogen, —OMe, —OEt, —CF3, —CHF2, —CH2F, methyl, ethyl, propyl, and isopropyl;
- R′ and R″ are each halogen;
- R1 is selected from —N(R21)C(O)R22, —N(R21)C(O)OR22, and —N(R21)C(O)N(R21)(R22);
- R21 is independently selected at each occurrence from hydrogen and C1-3 alkyl optionally substituted by one or more substituents independently selected from halogen, —OR17, —N(R17)2, and —CN;
- R22 is selected from C1-4 alkyl and C3-5 carbocycle, each of which is optionally substituted with one or two substituents independently selected from halogen, —OR18, —SR18, —N(R18)2, —C(O)R18, —C(O)OR18, C3-10 carbocycle and 3- to 10-membered heterocycle;
- wherein the C3-10 carbocycle and 3- to 10-membered heterocycle are each optionally substituted with one or more substituents selected from:
- halogen, —OR18, and —NO2;
- R11, R12, R13, R17, and R18 are independently selected at each occurrence from:
- hydrogen;
- C1-6 alkyl optionally substituted with one or more substituents independently selected from halogen, —OH, —O—C1-C6 alkyl, —O—C1-C6haloalkyl —NH2, —NO2, ═O, —CN, C3-10 carbocycle and 3- to 10-membered heterocycle;
- wherein the C3-10 carbocycle and 3- to 10-membered heterocycle are each optionally substituted with one or more substituents selected from:
- halogen, —OH, —O—C1-C6 alkyl, —O—C1-C6 haloalkyl —NH2, —NO2, ═O, and —CN;
- and
- C3-12 carbocycle and 3- to 12-membered heterocycle, each of which is optionally substituted with one or more substituents independently selected from:
- halogen, —OH, —O—C1-C6 alkyl, —O—C1-C6haloalkyl —NH2, —NO2, ═O, —CN;
- and
- C1-6 alkyl optionally substituted with one or more substituents independently selected from halogen, —OH, —O—C1-C6 alkyl, —O—C1-C6haloalkyl —NH2, —NO2, ═O, and —CN;
- and
- n is 0.
24 more elements
Dependencies are inferred from the claim text.